- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Decibel Therapeutics Inc is a biotechnology business based in the US. Decibel Therapeutics Inc shares (DBTX) are listed on the NASDAQ and all prices are listed in US Dollars. Decibel Therapeutics Inc employs 68 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Decibel Therapeutics stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Decibel Therapeutics Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DBTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Decibel Therapeutics Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Decibel Therapeutics Inc stock price (NASDAQ: DBTX)
Use our graph to track the performance of DBTX stocks over time.Decibel Therapeutics Inc shares at a glance
Information last updated 2023-11-19.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $4.61 |
| 200-day moving average | $3.77 |
| Wall St. target price | $10.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.54 |
Is it a good time to buy Decibel Therapeutics Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Decibel Therapeutics Inc financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -32.65% |
| Return on equity TTM | -76.76% |
| Profit margin | 0% |
| Book value | $2.12 |
| Market Capitalization | $123.4 million |
TTM: trailing 12 months
Decibel Therapeutics Inc share dividends
We're not expecting Decibel Therapeutics Inc to pay a dividend over the next 12 months.
You may also wish to consider:
Decibel Therapeutics Inc share price volatility
Over the last 12 months, Decibel Therapeutics Inc's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Decibel Therapeutics Inc's is -0.4025. This would suggest that Decibel Therapeutics Inc's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Decibel Therapeutics Inc has bucked the trend.
To put Decibel Therapeutics Inc's beta into context you can compare it against those of similar companies.
- Idera Pharmaceuticals (IDRA.US): 1.2979
- Leap Therapeutics (LPTX.US): 0.217
Decibel Therapeutics Inc overview
Decibel Therapeutics, Inc. , a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. The company's product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. Its lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. The company is also developing DB-ATO and AAV. 201, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the vestibule; DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial; AAV. 103 to restore hearing in individuals with a gap junction beta-2 (GJB2) deficiency; AAV.
Frequently asked questions
nullWhat percentage of Decibel Therapeutics Inc is owned by insiders or institutions?
Currently 13.355% of Decibel Therapeutics Inc shares are held by insiders and 61.95% by institutions. How many people work for Decibel Therapeutics Inc?
Latest data suggests 68 work at Decibel Therapeutics Inc. When does the fiscal year end for Decibel Therapeutics Inc?
Decibel Therapeutics Inc's fiscal year ends in December. Where is Decibel Therapeutics Inc based?
Decibel Therapeutics Inc's address is: 1325 Boylston Street, Boston, MA, United States, 02215 What is Decibel Therapeutics Inc's ISIN number?
Decibel Therapeutics Inc's international securities identification number is: US24343R1068
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question